Introduction to Ceftriaxone & Sulbactam 1.5gm Injection
Ceftriaxone & Sulbactam 1.5gm Injection is a combination antibiotic formulation containing Ceftriaxone, a third-generation cephalosporin, and Sulbactam, a beta-lactamase inhibitor. Together, they provide enhanced antibacterial coverage against a broader spectrum of resistant bacterial strains encountered in serious clinical infections.
Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, while Sulbactam irreversibly inhibits beta-lactamase enzymes produced by resistant bacteria. This dual action prevents enzymatic drug destruction, restoring and significantly enhancing Ceftriaxone’s bactericidal effectiveness against otherwise resistant and difficult-to-treat bacterial organisms.
Ceftriaxone & Sulbactam 1.5gm Injection is prescribed for treating complicated infections including hospital-acquired pneumonia, intra-abdominal infections, urinary tract infections, septicemia, skin infections, and surgical prophylaxis. Its enhanced spectrum makes it particularly valuable against beta-lactamase-producing resistant organisms in critically ill hospitalized patients.
Uses of Ceftriaxone & Sulbactam 1.5gm Injection
- Respiratory Tract Infections
- Urinary Tract Infections
- Intra-Abdominal Infections
- Skin and Soft Tissue Infections
- Bone and Joint Infections
- Central Nervous System Infections
- Bloodstream Infections
Strength
How Does Ceftriaxone & Sulbactam 1.5gm Injection Works?
Ceftriaxone & Sulbactam 1.5gm Injection works through a powerful dual mechanism. Ceftriaxone binds to penicillin-binding proteins, inhibiting bacterial cell wall synthesis and causing cell lysis. Simultaneously, Sulbactam irreversibly inhibits beta-lactamase enzymes, preventing bacterial destruction of Ceftriaxone and restoring its full bactericidal effectiveness.
Together, Ceftriaxone & Sulbactam 1.5gm Injection provides significantly enhanced antibacterial coverage against a broader spectrum of resistant gram-positive and gram-negative organisms. Sulbactam’s enzyme-inhibiting action ensures sustained therapeutic drug concentrations, overcoming resistance mechanisms and delivering superior clinical outcomes compared to Ceftriaxone monotherapy alone.
Side Effects of Ceftriaxone & Sulbactam 1.5gm Injection
Common Side Effects
- Injection Site Pain
- Redness & Swelling
- Nausea
- Vomiting
- Diarrhea
- Skin Rash
- Itching
Serious Side Effects
- Anaphylaxis
- Severe Rash
- Stevens-Johnson Syndrome
- Hemolytic Anemia
- Seizures
- Renal Toxicity
- Hepatotoxicity
Dosage
In adults, Ceftriaxone & Sulbactam 1.5gm Injection is typically administered once or twice daily via intramuscular or intravenous route. For moderate infections, 1.5gm daily is standard. Severe or life-threatening infections may require 3gm daily, administered under strict physician supervision.
In children, the recommended dose of Ceftriaxone & Sulbactam 1.5gm Injection is calculated at 50–75mg per kilogram of body weight daily. For severe infections like meningitis, doses up to 100mg/kg daily may be prescribed strictly under qualified pediatric specialist supervision throughout therapy.
Drug Interactions
- Anticoagulants
- Aminoglycosides
- Antifungals
- NSAIDs
- Calcium Solutions
- Immunosuppressants
Storage
- Temperature Store Ceftriaxone & Sulbactam Injection below 25°C at all times.
- Avoid Freezing Never freeze Ceftriaxone & Sulbactam vials, as freezing destroys active ingredients completely.
- Protect from Light Always keep vials protected from direct sunlight and strong artificial light.
- Dry Place Storage Store in a cool, dry place away from moisture and humidity.
- Reconstituted Solution Usage Use reconstituted Ceftriaxone & Sulbactam solution within 6 hours at room temperature.
- Refrigerated Solution Stability Refrigerated reconstituted solution at 2°C–8°C remains stable for up to 24 hours.
- Keep Away from Children Always store Ceftriaxone & Sulbactam safely out of children’s reach always.
Warnings & Precautions
1. Allergy History:
- Inform your doctor about any known hypersensitivity to cephalosporins, penicillins, or sulbactam before initiating Ceftriaxone & Sulbactam 1.5gm Injection therapy.
2. Renal Impairment:
- Patients with kidney disease must use Ceftriaxone & Sulbactam Injection cautiously, with appropriate dose adjustment and regular renal function monitoring throughout treatment.
3. Hepatic Impairment:
- Severe liver disease patients require careful dose adjustment, as both Ceftriaxone and Sulbactam are partially metabolized and excreted through hepatobiliary pathways during therapy.
4. Neonatal Precaution:
- Ceftriaxone & Sulbactam Injection is contraindicated in premature newborns and neonates with hyperbilirubinemia, as bilirubin displacement may cause serious irreversible neurological complications.
5. Pregnancy and Breastfeeding:
- Ceftriaxone & Sulbactam Injection should only be used during pregnancy or breastfeeding when clearly necessary and strictly under qualified medical supervision throughout therapy.
6. Superinfection Risk:
- Prolonged use of Ceftriaxone & Sulbactam Injection may encourage overgrowth of non-susceptible organisms; regular clinical monitoring is essential to detect secondary infections early.
7. Proper Reconstitution:
- Always reconstitute Ceftriaxone & Sulbactam 1.5gm Injection using the correct recommended diluent, following manufacturer guidelines precisely to ensure drug stability, sterility, and accurate dosing.


Reviews
There are no reviews yet.